More TrivarX Limited news
TrivarX LimitedASX: TRI

Termination of Underwriting Agreement

Mar 1, 2022 at 5:25 AM EST · Issued by TrivarX Limited

Filed with ASX · Mar 1, 2022 at 5:25 AM EST

On 6ix: 6ix.com/news/termination-of-underwriting-agreement

Trivarx Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

TrivarX Limited on 6ix

Story so far

  • Non-Renounceable Entitlement Offer Underwriting UpdateJan 20, 2022

Earlier from TrivarX

  • Non-Renounceable Entitlement Offer Underwriting UpdateJan 20, 2022
  • MEB to Raise up to $5.7 million by way of a Placement & NREODec 14, 2021
  • FDA Strategy and Regulatory UpdateOct 25, 2021
  • Appendix 4E and Annual ReportAug 31, 2021
  • MEB Appoints R&CPMK As Communications Agency in the USJun 24, 2021

Later from TrivarX

  • Medibio Announces Entitlement Offer ResultMar 10, 2022
  • FDA Confirm Diagnostic Method on Depression Validation TrialMay 18, 2022
  • Voluntary SuspensionJun 16, 2022
  • Reinstatement to QuotationJun 22, 2022
  • MEB to Raise $1.4m by way of a Placement & MD/CEO ResignsJun 22, 2022
All TrivarX news releases↗

Follow TrivarX into a list and get an email when it puts out news.

Follow TrivarX
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer